My career goal is to design and apply novel immunological approaches for treatment of advanced tumors of the head and neck. Patients with untreated and/or unresectable squamous cell carcinoma of the upper aerodigestive tract are particularly challenging to treat as they are often systemically immunosuppressed. Initial attempts to overcome this immunosuppression have utilized an approach termed adoptive immunotherapy. Adoptive immunotherapy involves injecting tumor cells into lymph nodes to generate tumor-specific T-cells, harvesting the T-cells, expanding and activating them ex vivo and infusing them into patients. Despite initial promise, adoptive transfer has met with only limited success, largely due to lack of efficient stimulation of tumoricidal T-cells. We hypothesize that the effectiveness of adoptive immunotherapy can be extended by in vivo priming of T-cells with dendritic cells (DC) loaded with tumor-derived heat shock proteins (HSP). Recently, it has been shown that HSP shuttle antigenic peptides to intracellular sites where MHC-peptide complexes are selected/assembled. When HSP are extracted from tumor cells, they carry nonselected intracellular peptides, e.g. tumor antigens, and such HSP have been successfully used for the induction of tumor-specific immunity. In this study, we will """"""""educate"""""""" DC ex vivo by loading with tumor specific HSP and subsequently use this DC/HSP vaccine for stimulation of tumoricidal T cells.
The specific aims of this proposal are to determine the efficacy of HSP-educated DC (DC/HSP) in stimulating a tumor-specific immune response; to determine the role of DC/HSP in preventing spontaneous tumor metastasis in murine melanoma model and to evaluate the role of DC/HSP in priming T cells derived from tumor-draining lymph nodes for use in adoptive immunotherapy. Successful accomplishment of these goals will provide scientific basis for improvement of adoptive immunotherapy of cancer and for development of clinical trials for treatment of patients suffering form advanced squamous cell carcinoma of the upper aerodigestive tract.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23DE000459-02
Application #
6379698
Study Section
NIDCR Special Grants Review Committee (DSR)
Program Officer
Lipton, James A
Project Start
2000-04-01
Project End
2005-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
2
Fiscal Year
2001
Total Cost
$119,988
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Weinman, Eric C; Roche, Patrick C; Kasperbauer, Jan L et al. (2003) Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma. Cancer 97:2203-11
Strome, Scott E; Dong, Haidong; Tamura, Hideto et al. (2003) B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res 63:6501-5
Graner, Darlene E; Foote, Robert L; Kasperbauer, Jan L et al. (2003) Swallow function in patients before and after intra-arterial chemoradiation. Laryngoscope 113:573-9
Strome, Scott E; Kawakami, Koji; Alejandro, Danielle et al. (2002) Interleukin 4 receptor-directed cytotoxin therapy for human head and neck squamous cell carcinoma in animal models. Clin Cancer Res 8:281-6
Wilcox, Ryan A; Tamada, Koji; Strome, Scott E et al. (2002) Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity. J Immunol 169:4230-6
Strome, Scott E; Voss, Stephen; Wilcox, Ryan et al. (2002) Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res 62:1884-9
Strome, Scott E; Martin, Elizabeth; Flies, Dallas et al. (2002) Reassessment of CD62L as a marker of pre-effector T cells in the tumor draining lymph nodes of head and neck cancer patients. Otolaryngol Head Neck Surg 126:180-7
Strome, Scott E; Weinman, Eric C (2002) Advanced larynx cancer. Curr Treat Options Oncol 3:11-20
Khurana, D; Martin, E A; Kasperbauer, J L et al. (2001) Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy. Head Neck 23:899-906